[Retracted] Combined RNAi Targeting Human Stat3 and ADAM9 As Gene Therapy for Non‑small Cell Lung Cancer

Liang Chang,Fangchao Gong,Hongfei Cai,Zhihong Li,Youbin Cui

DOI: https://doi.org/10.3892/ol.2022.13595

2022-01-01

Oncology Letters

Abstract:[This retracts the article DOI: 10.3892/ol.2015.4018.].

What problem does this paper attempt to address?

Author Correction: Targeted Inhibition of STAT/TET1 Axis As a Therapeutic Strategy for Acute Myeloid Leukemia

Xi Jiang,Chao Hu,Kyle Ferchen,Ji Nie,Xiaolong Cui,Chih-Hong Chen,Liting Cheng,Zhixiang Zuo,William Seibel,Chunjiang He,Yixuan Tang,Jennifer R. Skibbe,Mark Wunderlich,William C. Reinhold,Lei Dong,Chao Shen,Stephen Arnovitz,Bryan Ulrich,Jiuwei Lu,Hengyou Weng,Rui Su,Huilin Huang,Yungui Wang,Chenying Li,Xi Qin,James C. Mulloy,Yi Zheng,Jiajie Diao,Jie Jin,Chong Li,Paul P. Liu,Chuan He,Yuan Chen,Jianjun Chen

DOI: https://doi.org/10.1038/s41467-018-02947-0

IF: 16.6

2018-01-01

Nature Communications

Abstract:The original version of this Article contained an error in the spelling of the author James C. Mulloy, which was incorrectly given as James Mulloy. This has now been corrected in both the PDF and HTML versions of the Article.
Combined RNAi Targeting Human Stat3 and ADAM9 As Gene Therapy for Non-Small Cell Lung Cancer.

Liang Chang,Fangchao Gong,Hongfei Cai,Zhihong Li,Youbin Cui

DOI: https://doi.org/10.3892/ol.2015.4018

2015-01-01

Oncology Letters

Abstract:Previous studies have demonstrated that human signal transducer and activator of transcription 3 (Stat3) and disintegrin and metalloproteinase 9 (ADAM9) are promising targets for RNA interference (RNAi)-based gene therapy for human non-small cell lung cancer (NSCLC). Thus, in the present study, the recombinant lentiviral (Lv) small hairpin (sh)RNA expression plasmids Lv/sh-Stat3 and Lv/sh-ADAM9, which targeted Stat3 and ADAM9, respectively, were constructed and subsequently infected into the A549 human NSCLC cell line. Cell proliferation, migration, invasion and apoptosis were determined in vitro in A549 cells following treatment with Lv/sh-Stat3 or Lv/sh-ADAM9 alone or in combination. In addition, the combined effect of Lv/sh-Stat3 and Lv/sh-ADAM9 gene therapy was evaluated in vivo using A549 xenograft models in nude mice. The in vitro experiments demonstrated that A549 cells treated with a combination of Lv/sh-Stat3 and Lv/sh-ADAM9 exhibited a significant additive effect in their cell proliferation, migration, invasion and apoptosis abilities, compared with A549 cells treated with Lv/sh-Stat3 or Lv/sh-ADAM9 alone. The in vivo experiments conducted in A549 xenograft tumor mouse models revealed that the combined treatment with Lv/sh-Stat3 and Lv/sh-ADAM9 exerted an additive effect on tumor growth inhibition, compared with the treatment with Lv/sh-Stat3 or Lv/sh-ADAM9 alone. These results suggested that combined RNAi gene therapy targeting human Stat3 and ADAM9 may be a novel and promising strategy for the treatment of NSCLC.
Correction To: KIF5B-RET Fusion Kinase Promotes Cell Growth by Multilevel Activation of STAT3 in Lung Cancer

Yingying Qian,Shoujie Chai,Zuyu Liang,Yongfang Wang,You Zhou,Xia Xu,Chenchen Zhang,Min Zhang,Jingxing Si,Feiteng Huang,Zhangdan Huang,Wei Hong,Kai Wang

DOI: https://doi.org/10.1186/s12943-019-1093-0

IF: 37.3

2019-01-01

Molecular Cancer

Abstract:After the publication of this work [1],
Retracted: The Role of Cavin3 in the Progression of Lung Cancer and Its Mechanism

BioMed Research International

DOI: https://doi.org/10.1155/2024/9815768

2024-03-20

BioMed Research International

Abstract:[This retracts the article DOI: 10.1155/2020/6364801.].

biotechnology & applied microbiology,medicine, research & experimental
Retracted: AS-tDR-007872: A Novel tRNA-Derived Small RNA Acts an Important Role in Non-Small-Cell Lung Cancer

Computational and Mathematical Methods in Medicine

DOI: https://doi.org/10.1155/2023/9757631

IF: 2.809

2023-09-27

Computational and Mathematical Methods in Medicine

Abstract:[This retracts the article DOI: 10.1155/2022/3475955.].

mathematical & computational biology
Retracted: mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9

BioMed Research International

DOI: https://doi.org/10.1155/2024/9803876

2024-01-09

BioMed Research International

Abstract:[This retracts the article DOI: 10.1155/2021/6622342.].

biotechnology & applied microbiology,medicine, research & experimental
[Retracted] Long non‑coding RNA SNHG3 promotes the development of non‑small cell lung cancer via the miR‑1343‑3p/NFIX pathway

Lijun Zhao,Xue Song,Yesong Guo,Naixin Ding,Tingting Wang,Lei Huang

DOI: https://doi.org/10.3892/ijmm.2024.5421

Abstract:Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the Transwell cell migration and invasion assay data shown in Fig. 3B were strikingly similar to data appearing in different form in a pair of other articles written by different authors at different research institutes, one of which had already been published elsewhere prior to the submission of this paper to International Journal of Molecular Medicine, and one of which was under consideration for publication at around the same time. In view of the fact that the abovementioned data had already apparently been published previously, the Editor of International Journal of Molecular Medicine has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a satisfactory reply. The Editor apologizes to the readership for any inconvenience caused. [International Journal of Molecular Medicine 48: 147, 2021; DOI: 10.3892/ijmm.2021.4980].
Retraction Notice to: Decreased Lung Tumor Development in SwAPP Mice through the Downregulation of CHI3L1 and STAT 3 Activity via the Upregulation of miRNA342-3p

Dong Hun Lee,Ki Cheon Kim,Chul Ju Hwang,Kyung Ran Park,Young Suk Jung,Sun Young Kim,Ji Young Kim,Ju Kyung Song,Min Ji Song,Min Ki Choi,Dae Youn Hwang,Sang-Bae Han,Jin Tae Hong

DOI: https://doi.org/10.1016/j.omtn.2024.102266

2024-07-04

Abstract:[This retracts the article DOI: 10.1016/j.omtn.2019.02.007.].
Retracted: Understanding the Critical Role of Glycolysis-Related lncRNAs in Lung Adenocarcinoma Based on Three Molecular Subtypes

BioMed Research International

DOI: https://doi.org/10.1155/2024/9891572

2024-03-20

BioMed Research International

Abstract:[This retracts the article DOI: 10.1155/2022/7587398.].

biotechnology & applied microbiology,medicine, research & experimental
Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

Jiangsheng Xu,Yunhua Liu,Yujing Li,Hai Wang,Samantha Stewart,Kevin Van der Jeught,Pranay Agarwal,Yuntian Zhang,Sheng Liu,Gang Zhao,Jun Wan,Xiongbin Lu,Xiaoming He

DOI: https://doi.org/10.1038/s41565-019-0417-y

IF: 38.3

2019-01-01

Nature Nanotechnology

Abstract:The Supplementary Information originally published with this Article was an older version, in which ‘IFN-γ’ was misspelled ‘INF-γ’ in Supplementary Fig. 9 and the β-Actin blot in Supplementary Fig. 13 was the wrong image. The Supplementary Information has now been replaced.
[Retracted] Long non‐coding RNA Igf2as controls hepatocellular carcinoma progression through the ERK/MAPK signaling pathway

Han Bao,Chun-Guang Guo,Peng-Cheng Qiu,Xin-Lei Zhang,Qi Dong,Yu-Kun Wang

DOI: https://doi.org/10.3892/ol.2024.14686

2024-09-20

Oncology Letters

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the flow cytometric data shown in Fig. 2C, the Hoechst 33342‐stained images in Fig. 2D, the colony formation assay data shown in Fig. 3A, the cell invasion assay data in Fig. 3B and the cell proliferation assay data shown in Fig. 3C had already appeared in previously published articles written by different authors at different research institutes, or were featured in an article that was submitted for publication to a different journal at around the same time. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Letters , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Letters 14: 2831‐2837, 2017; DOI: 10.3892/ol.2017.6492]

oncology
[Retracted] AdipoR1‐mediated miR‐3908 inhibits glioblastoma tumorigenicity through downregulation of STAT2 associated with the AMPK/SIRT1 pathway

Xiangming Liu,Jinglong Chen,Jinqian Zhang

DOI: https://doi.org/10.3892/or.2024.8697

2024-01-06

Oncology Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the western blotting data shown in Figs. 3B and 9, and the migration assay data shown in Fig. 6C, were strikingly similar to data that had already appeared in other publications written by different authors at different research institutes. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Reports , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 37: 3387‐3396, 2017; DOI: 10.3892/or.2017.5589]

oncology
[Retracted] MicroRNA‐30a suppresses the proliferation, migration and invasion of human renal cell carcinoma cells by directly targeting ADAM9

Lining Jiang,Yabin Liu,Can Ma,Binghui Li

DOI: https://doi.org/10.3892/ol.2024.14232

2024-01-16

Oncology Letters

Abstract:Subsequently to the publication of this paper, the authors contacted the Editorial Office to explain that, during the preparation of the data in Figs. 2C and 4D, they inadvertently included two sets of different data to represent the same experiments, and that, in fact, only the set of data panels featured on the left for each of the figure parts was intended to have been included in these figures. The authors requested the publication of a corrigendum; however, after a subsequent investigation of the matter in the Office, as many as three pairs of overlapping data panels were identified comparing the data panels that were intended to have been included in the figures with those that were not. After careful consideration, the Editor of Oncology Letters has decided that the paper should be retracted from the journal on account of a lack of overall confidence in the originally presented data. Upon contacting the authors, they accepted the Editor's decision to retract the article. The Editor regrets any inconvenience caused to the readership.[Oncology Letters 16: 3038‐3044, 2018; DOI: 10.3892/ol.2018.8999]

oncology
[Retracted] MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3

Shan Xu,Ning Zhao,Lian Hui,Min Song,Zi-Wei Miao,Xue-Jun Jiang

DOI: https://doi.org/10.3892/or.2024.8807

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the cell apoptotic data in Fig. 4 on p. 1389 and the migration and invasion assay data shown in Figs. 6 and 7 on p. 1391 were strikingly similar to data that were submitted for publication at around the same time in different articles written by different authors at different research institutes (several of which have subsequently been retracted). In addition, there appeared to be instances of duplication of the same data within Figs. 7 and 8, where data that were intending to have shown the results from differently performed experiments had apparently been derived from the same original sources. Owing to the fact that the contentious data in the above article had already been submitted for publication elsewhere prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 35: 1385-1394, 2016; DOI: 10.3892/or.2015.4524].
Mannose Suppresses the Proliferation and Metastasis of Lung Cancer by Targeting the ERK/GSK-3β/β-Catenin/SNAIL Axis [Retraction]

Qingsong Luo,Bei Li,Gang Li

DOI: https://doi.org/10.2147/ott.s461193

IF: 4

2024-01-01

OncoTargets and Therapy

Abstract:[This retracts the article DOI: 10.2147/OTT.S241816.].

oncology,biotechnology & applied microbiology
Retraction Note: High Expression of RIOK2 and NOB1 Predict Human Non-small Cell Lung Cancer Outcomes

Kun Liu,Hong-Lin Chen,Shuo Wang,Ming-Ming Gu,Xin-Ming Chen,Shuang-Long Zhang,Kang-Jun Yu,Qing-Sheng You

DOI: https://doi.org/10.1038/s41598-023-32033-5

IF: 4.6

2023-03-23

Scientific Reports

Abstract:Editor's Note: this Article has been retracted; the Retraction Note is available at https://doi.org/10.1038/s41598-023-32033-5

multidisciplinary sciences
[Retracted] MicroRNA‐219 is downregulated in non‐small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2

Xiaoping Sun,Min Xu,Haiyan Liu,Kunxiu Ming

DOI: https://doi.org/10.3892/mmr.2024.13237

IF: 3.423

2024-05-10

Molecular Medicine Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell migration and invasion assay data shown in Figs. 2C and 4C were strikingly similar to data that had already been published in different form in another article written by different authors at a different research institute [Yang S, Zhang Y, Zhao X, Wang J and Shang J: microRNA‐361 targets Wilms' tumor 1 to inhibit the growth, migration and invasion of non‐small‐cell lung cancer cells. Mol Med Rep 14: 5415‐5421, 2016]. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 16: 3557‐3564, 2017; DOI: 10.3892/mmr.2017.7000]

oncology,medicine, research & experimental
Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (Nature Nanotechnology, (2019), 14, 4, (388-397), 10.1038/s41565-019-0381-6)

Jiangsheng Xu,Yunhua Liu,Yujing Li,Hai Wang,Samantha Stewart,Kevin Van der Jeught,Pranay Agarwal,Yuntian Zhang,Sheng Liu,Gang Zhao,Jun Wan,Xiongbin Lu,Xiaoming He

DOI: https://doi.org/10.1038/S41565-019-0417-Y

IF: 38.3

2019-01-01

Nature Nanotechnology

Abstract:The Supplementary Information originally published with this Article was an older version, in which ‘IFN-γ’ was misspelled ‘INF-γ’ in Supplementary Fig. 9 and the β-Actin blot in Supplementary Fig. 13 was the wrong image. The Supplementary Information has now been replaced.
Retracted: IL-32 Promotes the Radiosensitivity of Esophageal Squamous Cell Carcinoma Cell through STAT3 Pathway

BioMed Research International

DOI: https://doi.org/10.1155/2024/9796319

2024-01-09

BioMed Research International

Abstract:[This retracts the article DOI: 10.1155/2021/6653747.].

biotechnology & applied microbiology,medicine, research & experimental
[Retracted] Tissue‐specific transplantation antigen P35B functions as an oncogene and is regulated by microRNA‐125a‐5p in lung cancer

Yingjie Gao,Guangliang Zhang,Jinlong Liu,Huimin Li

DOI: https://doi.org/10.3892/or.2024.8735

2024-04-17

Oncology Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the immunohistochemical data shown in Fig. 1A on p. 5, colony formation data shown in Figs. 2C, H and M and 6D on p. 6 and p. 10 respectively, the western blots in Fig. 2B, Transwell cell migration and invasion assay data in Fig. 3B, D and F, and immunofluorescence data in Fig. 4C had already appeared in previously published articles written by different authors at different research institutes (some of which have subsequently been retracted). Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Reports , the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they accepted the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 45: 72, 2021; DOI: 10.3892/or.2021.8023]

oncology

[Retracted] Combined RNAi Targeting Human Stat3 and ADAM9 As Gene Therapy for Non‑small Cell Lung Cancer

Author Correction: Targeted Inhibition of STAT/TET1 Axis As a Therapeutic Strategy for Acute Myeloid Leukemia

Combined RNAi Targeting Human Stat3 and ADAM9 As Gene Therapy for Non-Small Cell Lung Cancer.

Correction To: KIF5B-RET Fusion Kinase Promotes Cell Growth by Multilevel Activation of STAT3 in Lung Cancer

Retracted: The Role of Cavin3 in the Progression of Lung Cancer and Its Mechanism

Retracted: AS-tDR-007872: A Novel tRNA-Derived Small RNA Acts an Important Role in Non-Small-Cell Lung Cancer

Retracted: mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9

[Retracted] Long non‑coding RNA SNHG3 promotes the development of non‑small cell lung cancer via the miR‑1343‑3p/NFIX pathway

Retraction Notice to: Decreased Lung Tumor Development in SwAPP Mice through the Downregulation of CHI3L1 and STAT 3 Activity via the Upregulation of miRNA342-3p

Retracted: Understanding the Critical Role of Glycolysis-Related lncRNAs in Lung Adenocarcinoma Based on Three Molecular Subtypes

Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

[Retracted] Long non‐coding RNA Igf2as controls hepatocellular carcinoma progression through the ERK/MAPK signaling pathway

[Retracted] AdipoR1‐mediated miR‐3908 inhibits glioblastoma tumorigenicity through downregulation of STAT2 associated with the AMPK/SIRT1 pathway

[Retracted] MicroRNA‐30a suppresses the proliferation, migration and invasion of human renal cell carcinoma cells by directly targeting ADAM9

[Retracted] MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3

Mannose Suppresses the Proliferation and Metastasis of Lung Cancer by Targeting the ERK/GSK-3β/β-Catenin/SNAIL Axis [Retraction]

Retraction Note: High Expression of RIOK2 and NOB1 Predict Human Non-small Cell Lung Cancer Outcomes

[Retracted] MicroRNA‐219 is downregulated in non‐small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2

Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (Nature Nanotechnology, (2019), 14, 4, (388-397), 10.1038/s41565-019-0381-6)

Retracted: IL-32 Promotes the Radiosensitivity of Esophageal Squamous Cell Carcinoma Cell through STAT3 Pathway

[Retracted] Tissue‐specific transplantation antigen P35B functions as an oncogene and is regulated by microRNA‐125a‐5p in lung cancer